Jordi Salas-Salvadó

Catedrático de Nutrición. Director de la Unidad de Nutrición Humana de la Universidad Rovira i Virgili. Tarragona. Investigador principal de CIBERobn, Instituto Carlos III, Madrid.

Distinguished Professor of Nutrition and Director of the Human Nutrition Unit - University Rovira i Virgili (URV) and ICREA Academia Investigator, CIBERobn Principal Investigator and Coordinator of its Nutrition Programme. He is currently Director of the Catalan Nutrition Centre (CCNIEC), President of the World Forum for Nutrition Research and Dissemination (INC), and a member of the expert panel of the Diabetes and Nutrition Study Group (DSNG). Prof Salas' research has focused on human clinical trials to evaluate the effects of foods, dietary compounds and dietary patterns on obesity, diabetes, metabolic syndrome and cardiovascular disease. Since 2005, he has been one of the principal investigators of the PREDIMED study (n=7447 participants) and is currently the coordinator and chairman of the steering committee of the PREDIMED-Plus study (n=6874 participants), two large clinical trials for the primary prevention of cardiovascular disease and mortality. PREDIMED-Plus is a multi-collaborative project involving 30 research groups and has received national, European, Canadian and US grants. Through all these projects and collaborations, the group has developed skills in precision medicine using different OMIC methodologies, in particular metabolomics and metagenomics, which we are now implementing in epidemiological and clinical studies. He is also involved in two prospective national and international cohort studies: CORALS (children followed for 10 years) and LEDFERTYL (men of reproductive age). He has published more than 810 scientific articles with more than 45000 citations and an SCI H-index of 105, has published 14 books and has supervised 40 PhD students. Has been named one of the world's most influential researchers by Clarivate Analytics and Standford University.